Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
Clinical trial NCT04079374 · UNKNOWN
Trial details
- NCT number
- NCT04079374
- Sponsor
- Joint Stock Company "Farmak"
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-03
- Primary completion
- 2021-12-03
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.